ATE362489T1 - Verfahren zur modulierung der proliferation von medullären schilddrüsen-karzinomzellen - Google Patents

Verfahren zur modulierung der proliferation von medullären schilddrüsen-karzinomzellen

Info

Publication number
ATE362489T1
ATE362489T1 AT02725077T AT02725077T ATE362489T1 AT E362489 T1 ATE362489 T1 AT E362489T1 AT 02725077 T AT02725077 T AT 02725077T AT 02725077 T AT02725077 T AT 02725077T AT E362489 T1 ATE362489 T1 AT E362489T1
Authority
AT
Austria
Prior art keywords
cys
carcinoma cells
thyroid carcinoma
medullary thyroid
modulating proliferation
Prior art date
Application number
AT02725077T
Other languages
English (en)
Inventor
Uberti Ettore Degli
Maria Zatelli
Michael Culler
Original Assignee
Il Consorzio Ferrara Richerche
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Il Consorzio Ferrara Richerche, Sod Conseils Rech Applic filed Critical Il Consorzio Ferrara Richerche
Application granted granted Critical
Publication of ATE362489T1 publication Critical patent/ATE362489T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02725077T 2001-03-06 2002-03-06 Verfahren zur modulierung der proliferation von medullären schilddrüsen-karzinomzellen ATE362489T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27369901P 2001-03-06 2001-03-06

Publications (1)

Publication Number Publication Date
ATE362489T1 true ATE362489T1 (de) 2007-06-15

Family

ID=23045039

Family Applications (3)

Application Number Title Priority Date Filing Date
AT02725077T ATE362489T1 (de) 2001-03-06 2002-03-06 Verfahren zur modulierung der proliferation von medullären schilddrüsen-karzinomzellen
AT07006462T ATE466029T1 (de) 2001-03-06 2002-03-06 Verfahren zur modulation der proliferation von schilddrüsenkrebszellen
AT07006463T ATE430162T1 (de) 2001-03-06 2002-03-06 Verfahren zur modulation der proliferation von schilddrüsenkrebszellen

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT07006462T ATE466029T1 (de) 2001-03-06 2002-03-06 Verfahren zur modulation der proliferation von schilddrüsenkrebszellen
AT07006463T ATE430162T1 (de) 2001-03-06 2002-03-06 Verfahren zur modulation der proliferation von schilddrüsenkrebszellen

Country Status (10)

Country Link
US (3) US20050124549A1 (de)
EP (3) EP1813625B1 (de)
JP (2) JP4294959B2 (de)
AT (3) ATE362489T1 (de)
CA (2) CA2743731C (de)
DE (3) DE60232203D1 (de)
ES (3) ES2284859T3 (de)
NO (1) NO20033881L (de)
RU (3) RU2352578C2 (de)
WO (1) WO2002070555A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262229B1 (en) * 1996-12-04 2001-07-17 Biomeasure Incorporated Somatostatin antagonists
RU2352578C2 (ru) * 2001-03-06 2009-04-20 Иль Консорцио Феррара Ричерке Способ модуляции пролиферации клеток медуллярной карциномы щитовидной железы
DK1372688T3 (da) * 2001-03-08 2008-08-25 Univ Tulane Somatostatin-antagonister
EP1522311A1 (de) * 2003-10-10 2005-04-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verwendung von Somatostatin oder seine Derivate zur Herstellung eines Medikamentes zur Regulierung der Ovarialfollikelnreserve bei der nicht menopausierte Frau
GB0602639D0 (en) 2006-02-09 2006-03-22 Novartis Ag Organic compounds
WO2007112045A2 (en) 2006-03-23 2007-10-04 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Use of somatostatin agonists to treat medullary thyroid carcinoma
EP2835136A1 (de) 2013-08-07 2015-02-11 PregLem S.A. Somatostatin Receptor Modulator zur Unfruchtbarkeitsbehandlung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661472A (en) * 1985-05-09 1987-04-28 The Salk Institute For Biological Studies GnRH antagonists IX
US5244883A (en) * 1990-11-29 1993-09-14 The Administrators Of The Tulane Educational Fund Nonapeptide bombesin antagonists
EP1288224B1 (de) 1993-08-09 2008-06-25 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Derivate therapeutischer Peptide
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
GB9513224D0 (en) * 1995-06-29 1995-09-06 Sandoz Ltd Organic compounds
US5972893A (en) * 1997-05-06 1999-10-26 Cedars-Sinai Medical Center Method of treating hyperprolactinemia and prolactinomas
PT979098E (pt) 1997-05-01 2003-07-31 Cedars Sinai Medical Center Metodo para o tratamento da hiperprolactinemia e de prolactinomas
US6180082B1 (en) * 1997-11-24 2001-01-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method to enhance tissue accumulation of radiolabeled compounds
JP2001513114A (ja) 1997-11-24 2001-08-28 ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティー アンド アグリカルチュラル アンド メカニカル カレッジ 放射性同位元素標識した化合物の組織への蓄積を促進するための方法
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
IL140837A0 (en) 1998-07-30 2002-02-10 Sod Conseils Rech Applic Method of using lanreotide, a somatostatin analogue
CN1367792A (zh) * 1999-06-25 2002-09-04 研究及应用科学协会股份有限公司 促生长素抑制素激动剂
RU2352578C2 (ru) * 2001-03-06 2009-04-20 Иль Консорцио Феррара Ричерке Способ модуляции пролиферации клеток медуллярной карциномы щитовидной железы

Also Published As

Publication number Publication date
RU2275934C2 (ru) 2006-05-10
EP1390406B1 (de) 2007-05-16
RU2007111864A (ru) 2008-10-10
DE60236225D1 (de) 2010-06-10
DE60220157D1 (de) 2007-06-28
EP1813625B1 (de) 2009-04-29
ATE430162T1 (de) 2009-05-15
EP1390406A2 (de) 2004-02-25
CA2743731A1 (en) 2002-09-12
ES2284859T3 (es) 2007-11-16
ATE466029T1 (de) 2010-05-15
CA2440214A1 (en) 2002-09-12
ES2328077T3 (es) 2009-11-06
DE60220157T2 (de) 2008-01-17
EP1813625A1 (de) 2007-08-01
EP1897889A2 (de) 2008-03-12
RU2003129515A (ru) 2005-03-27
US20070259811A1 (en) 2007-11-08
EP1897889A3 (de) 2008-03-26
RU2317824C2 (ru) 2008-02-27
US20050124549A1 (en) 2005-06-09
WO2002070555A2 (en) 2002-09-12
RU2352578C2 (ru) 2009-04-20
EP1897889B1 (de) 2010-04-28
NO20033881D0 (no) 2003-09-02
CA2440214C (en) 2012-05-22
JP4294959B2 (ja) 2009-07-15
JP4828438B2 (ja) 2011-11-30
US20110183416A1 (en) 2011-07-28
JP2007145854A (ja) 2007-06-14
RU2005132456A (ru) 2007-04-27
NO20033881L (no) 2003-10-10
US9220760B2 (en) 2015-12-29
JP2005506289A (ja) 2005-03-03
DE60232203D1 (de) 2009-06-10
WO2002070555A3 (en) 2003-12-04
CA2743731C (en) 2014-05-06
ES2345280T3 (es) 2010-09-20

Similar Documents

Publication Publication Date Title
YU25497A (sh) Postupak za dobijanje sildenafila
DE69128516D1 (de) Neue Mercaptoacetylamid-Derivate zur Verwendung als Enkephalinase- und ACE-Hemmer
DE69738815D1 (de) Verwendung von Cyclooxygenase-2 Inhibitoren zur Behandlung und Vorbeugung von Neoplasia
EA199900643A1 (ru) Сульфамидные ингибиторы металлопротеаз
ATE220317T1 (de) Verwendung von betainen als antitranspirantien
EA200301100A1 (ru) Новые фталазиноны
NZ337531A (en) Substituted benzamides as immunomodulator for normalisation of IL-10/IL/12 balance
EP0975353A4 (de) Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren
PL352638A1 (en) Novel derivatives and analogues of galanthamin
GB9715030D0 (en) Metalloproteinase inhibitors
ATE199710T1 (de) Aromatische diselenide und selenosulfide zur verwendung als antioxidans-mittel
DE60220157D1 (de) Verfahren zur modulierung der proliferation von medullären schilddrüsen-karzinomzellen
ATE211719T1 (de) Korrosionsinhibitoren enthaltender injektionszement
DE60125378D1 (de) Verfahren zur herstellung von 2-aminomethyl-halogen-pyridinen
EA200400806A1 (ru) Способ получения эхинокандиновых соединений
DK1377574T3 (da) 6-phenylbenzonaphtyridiner
ATE339475T1 (de) Verfahren zur hydrophilierung von fluoreszierenden markierstoffen
DE69431824D1 (de) Verfahren zur Herstellung von Schwefelhaltigen Imidazolderivaten und erhaltene Zwischenprodukte
DE60224884D1 (de) Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
WO2002053537A8 (en) Process for preparing (±) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
PT1156999E (pt) Metodo para a preparacao de um beta-aminoester quiral
DE60001298D1 (de) Verfahren zur Herstellung von Omeprazol
ATE265854T1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties